BR0011950A - Solução de xilometazolina e oximetazolina estável - Google Patents

Solução de xilometazolina e oximetazolina estável

Info

Publication number
BR0011950A
BR0011950A BR0011950-4A BR0011950A BR0011950A BR 0011950 A BR0011950 A BR 0011950A BR 0011950 A BR0011950 A BR 0011950A BR 0011950 A BR0011950 A BR 0011950A
Authority
BR
Brazil
Prior art keywords
xylometazoline
stable
solution
oxymetazoline
oxymetazoline solution
Prior art date
Application number
BR0011950-4A
Other languages
English (en)
Inventor
Frieder Ulrich Maerz
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23322017&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0011950(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BR0011950A publication Critical patent/BR0011950A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Cosmetics (AREA)

Abstract

Patente de Invenção: "SOLUçãO DE XILOMETAZOLINA E OXIMETAZOLINA ESTáVEL". A presente invenção refere-se a uma solução de xilometazolina e/ou oximetazolina estável biologica e quimicamente com glicerol e/ou sorbitol como coadjuvante.
BR0011950-4A 1999-06-22 2000-06-17 Solução de xilometazolina e oximetazolina estável BR0011950A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33778999A 1999-06-22 1999-06-22
PCT/EP2000/005583 WO2000078297A2 (de) 1999-06-22 2000-06-17 Stabile xylometazolin- und oxymetazolinlösung

Publications (1)

Publication Number Publication Date
BR0011950A true BR0011950A (pt) 2002-03-12

Family

ID=23322017

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0011950-4A BR0011950A (pt) 1999-06-22 2000-06-17 Solução de xilometazolina e oximetazolina estável

Country Status (22)

Country Link
US (2) US20040191177A1 (pt)
EP (1) EP1194145B1 (pt)
JP (1) JP2003502361A (pt)
KR (1) KR20020012001A (pt)
CN (1) CN1164271C (pt)
AT (1) ATE232099T1 (pt)
AU (1) AU765736B2 (pt)
BR (1) BR0011950A (pt)
CA (1) CA2376121C (pt)
CZ (1) CZ295595B6 (pt)
DE (1) DE50001217D1 (pt)
EA (1) EA003329B1 (pt)
ES (1) ES2188563T3 (pt)
HK (1) HK1045945B (pt)
HU (1) HUP0201700A3 (pt)
IL (1) IL147023A0 (pt)
MX (1) MXPA01012912A (pt)
PL (1) PL197542B1 (pt)
PT (1) PT1194145E (pt)
TR (1) TR200103694T2 (pt)
WO (1) WO2000078297A2 (pt)
ZA (1) ZA200110386B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226527B1 (hu) 2001-09-18 2009-03-30 Nycomed Danmark Aps Készítmények nátha kezelésére
NZ537186A (en) * 2002-06-20 2006-10-27 Novartis Consumer Health S Nasal compositions comprising a mucopolysaccharide and propylene glycol
US7714011B2 (en) * 2002-09-13 2010-05-11 Zicam, Llc Compositions to reduce congestion and methods for application thereof to the nasal membrane
DE10337186A1 (de) * 2003-08-13 2005-03-17 Merck Patent Gmbh Wässrige Wirkstoff-Lösung
EP2015733A2 (en) * 2006-04-26 2009-01-21 Aciex, Inc. Compositions for the treatment and prevention of eyelid swelling
US20090136598A1 (en) * 2006-04-26 2009-05-28 Aciex, Inc. Compositions for the Treatment and Prevention of Eyelid Swelling
CN101912363A (zh) * 2010-07-29 2010-12-15 蔡海德 溶解超滤-喷雾干燥-分子分散包衣-水化制粒-冷冻干燥生产脂质体组合药物
WO2016102984A1 (en) 2014-12-24 2016-06-30 Jadran - Galenski Laboratorij D.D. A nasal composition containing sea water as stability-improving excipient
WO2023046590A1 (en) 2021-09-22 2023-03-30 Jadran - Galenski Laboratorij D.D. An improved pharmaceutical composition for nasal use, preparation, and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603131A (en) * 1982-04-26 1986-07-29 Bernstein Joel E Method and composition for treating and preventing irritation of the mucous membranes of the nose
US4970240A (en) * 1989-10-18 1990-11-13 Schering Corporation Fruity flavored nasal decongestant composition
US5114979A (en) * 1989-10-18 1992-05-19 Schering Corporation Fruity flavored nasal decongestant composition
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
DE19549421C2 (de) * 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
ES2190477T3 (es) * 1995-11-17 2003-08-01 Ursatec Verpackung Gmbh Dispensador de fluidos diseñado para proteger el contenido de la contaminacion.
DE19542959C1 (de) * 1995-11-17 1996-10-24 Ursatec Verpackung Gmbh Vor Kontamination schützende Abgabevorrichtung für Fluide
PT1051155E (pt) * 1998-01-30 2002-10-31 Novartis Consumer Health Sa Solucoes nasais

Also Published As

Publication number Publication date
CN1164271C (zh) 2004-09-01
AU6150600A (en) 2001-01-09
CZ20014568A3 (cs) 2002-03-13
DE50001217D1 (de) 2003-03-13
EA200200042A1 (ru) 2002-06-27
WO2000078297A2 (de) 2000-12-28
CZ295595B6 (cs) 2005-08-17
CA2376121C (en) 2008-06-10
PL352354A1 (en) 2003-08-11
PT1194145E (pt) 2003-06-30
KR20020012001A (ko) 2002-02-09
TR200103694T2 (tr) 2002-04-22
ATE232099T1 (de) 2003-02-15
CN1361689A (zh) 2002-07-31
HK1045945B (zh) 2005-01-28
AU765736B2 (en) 2003-09-25
US20080011293A1 (en) 2008-01-17
HUP0201700A3 (en) 2003-02-28
ES2188563T3 (es) 2003-07-01
MXPA01012912A (es) 2002-09-18
ZA200110386B (en) 2003-04-22
WO2000078297A3 (de) 2001-03-01
US20040191177A1 (en) 2004-09-30
IL147023A0 (en) 2002-08-14
EA003329B1 (ru) 2003-04-24
PL197542B1 (pl) 2008-04-30
HK1045945A1 (en) 2002-12-20
EP1194145A2 (de) 2002-04-10
HUP0201700A2 (hu) 2002-12-28
CA2376121A1 (en) 2000-12-28
EP1194145B1 (de) 2003-02-05
JP2003502361A (ja) 2003-01-21

Similar Documents

Publication Publication Date Title
DE50010677D1 (de) Neuartige aminodicarbonsäurederivate mit pharmazeutischen eigenschaften
BR0014214A (pt) Imidazoquinolinas substituìdas com amida
BR0009480A (pt) Soluções de poliuretano com unidades de estrutura de alcoxissilano
BR0116464A (pt) imidazoquinolinas substituìdas com amido éter
BR0011433A (pt) Imidazoquinolinas substituìdas com sulfonamida e sulfamida
ATE240334T1 (de) Pyrrolobenzodiazepine
DE50102337D1 (de) Mikronisiertes bariumsulfat
DE60042375D1 (de) Verfahren zur Herstellung von 3,3-Dimethylbutanal
BR0211502A (pt) Derivados de ácido acético de indano e seu uso como agentes farmacêuticos, intermediários, e método de preparação
IT1319202B1 (it) Farmaci per le malattie a base infiammatoria.
BR0011950A (pt) Solução de xilometazolina e oximetazolina estável
SV1996000051A (es) Formulaciones orales de etodolac s (+)
HN1998000088A (es) Tratamiento de resistencia a la insulina
ES2422081T3 (es) Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
BRPI0302496B8 (pt) composições farmacêuticas com atividade antibiótica
BR0115139A (pt) Compostos bis-heterocìclicos com atividade antitumor e quimiossensibilizante
AU2001281880A1 (en) Use of a formulation made of or containing at least one dissimilated milk serum
DE60113304D1 (de) Verwendung von langem pentraxin ptx3 zur herstellung eines arzneimittels zur verhütung und heilung von autoimmunkrankheiten
ITMI20032172A1 (it) Procedimento atto alla correzione dell'arricchimento di
DE60224884D1 (de) Verfahren zur herstellung von 3, 3', 6, 6'-tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'-tetraalkylen-5, 5'-dihalo-2, 2' biphenolen
BRPI0408405A (pt) pigmentos de óxido de ferro
NO20021856L (no) Koplingsdal
BRPI0409586A (pt) ácidos hidroxámicos úteis no tratamento de distúrbios hiperproliferativos
IT1312060B1 (it) Uso dell'acido alfa lipoico nel trattamento antimetastatico.

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 31/00

Ipc: A61K 31/415 (2009.01)

B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements